Menu
GeneBe

MST1R

macrophage stimulating 1 receptor, the group of CD molecules|IPT domain containing|Receptor tyrosine kinases

Basic information

Region (hg38): 3:49887001-49903873

Previous symbols: [ "RON", "PTK8", "SEA" ]

Links

ENSG00000164078NCBI:4486OMIM:600168HGNC:7381Uniprot:Q04912AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • nasopharyngeal carcinoma, susceptibility to, 3 (Limited), mode of inheritance: AD

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MST1R gene.

  • Inborn genetic diseases (50 variants)
  • not provided (15 variants)
  • not specified (1 variants)
  • Nasopharyngeal carcinoma, susceptibility to, 3 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MST1R gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
4
clinvar
6
missense
47
clinvar
5
clinvar
5
clinvar
57
nonsense
2
clinvar
2
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 47 9 9

Variants in MST1R

This is a list of pathogenic ClinVar variants found in the MST1R region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
3-49887339-G-A not specified Uncertain significance (Sep 27, 2021)2395114
3-49887356-C-A MST1R-related disorder • not specified Conflicting classifications of pathogenicity (Jul 14, 2021)2324909
3-49887369-A-G not specified Likely benign (Feb 28, 2023)2491557
3-49887381-G-A Uncertain significance (-)1049215
3-49887468-G-T not specified Uncertain significance (Mar 02, 2023)2472967
3-49887507-T-C MST1R-related disorder Benign (Oct 21, 2019)3058886
3-49887514-G-A Benign (Dec 31, 2019)708319
3-49889957-C-T not specified Uncertain significance (Aug 04, 2023)2592365
3-49889961-G-A not specified Uncertain significance (Mar 07, 2023)2495095
3-49890070-G-T MST1R-related disorder Benign (Dec 16, 2019)3055583
3-49890531-G-A not specified Uncertain significance (Dec 07, 2021)2229464
3-49890546-G-A not specified Uncertain significance (Apr 11, 2023)2518499
3-49890552-C-T not specified Uncertain significance (Aug 08, 2022)2345630
3-49890576-C-G not specified Uncertain significance (Oct 06, 2023)3212718
3-49890601-C-T not specified Uncertain significance (Apr 10, 2023)2524697
3-49890602-G-A Benign (Dec 31, 2019)727440
3-49890603-C-T not specified Uncertain significance (Jan 31, 2024)3212715
3-49891261-G-A not specified Uncertain significance (Jan 26, 2022)2404258
3-49891263-G-A not specified Uncertain significance (Aug 02, 2021)2215922
3-49891401-G-A not specified Uncertain significance (Oct 12, 2021)2342070
3-49891412-C-T not specified Uncertain significance (Aug 16, 2021)2363885
3-49891421-T-C not specified Uncertain significance (Dec 20, 2023)3212704
3-49891445-T-C not specified Uncertain significance (Jan 26, 2022)2220349
3-49891485-T-C not specified Likely benign (Feb 17, 2024)3212697
3-49891557-C-T not specified Uncertain significance (Dec 11, 2023)3212694

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MST1Rprotein_codingprotein_codingENST00000296474 2016865
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
7.87e-370.0000048012499337521257480.00301
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.6827968520.9340.00005478943
Missense in Polyphen268296.260.904613292
Synonymous1.413263600.9050.00002293080
Loss of Function-0.05925554.51.010.00000297578

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.02110.0209
Ashkenazi Jewish0.002180.00218
East Asian0.001520.00152
Finnish0.002260.00222
European (Non-Finnish)0.001960.00195
Middle Eastern0.001520.00152
South Asian0.001770.00173
Other0.0008160.000815

dbNSFP

Source: dbNSFP

Function
FUNCTION: Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to MST1 ligand. Regulates many physiological processes including cell survival, migration and differentiation. Ligand binding at the cell surface induces autophosphorylation of RON on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with the PI3-kinase subunit PIK3R1, PLCG1 or the adapter GAB1. Recruitment of these downstream effectors by RON leads to the activation of several signaling cascades including the RAS-ERK, PI3 kinase-AKT, or PLCgamma-PKC. RON signaling activates the wound healing response by promoting epithelial cell migration, proliferation as well as survival at the wound site. Plays also a role in the innate immune response by regulating the migration and phagocytic activity of macrophages. Alternatively, RON can also promote signals such as cell migration and proliferation in response to growth factors other than MST1 ligand. {ECO:0000269|PubMed:18836480, ECO:0000269|PubMed:7939629, ECO:0000269|PubMed:9764835}.;
Disease
DISEASE: Nasopharyngeal carcinoma, 3 (NPCA3) [MIM:617075]: A form of nasopharyngeal carcinoma, a malignant neoplasm that originates in the nasopharyngeal epithelium and includes 4 subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and papillary adenocarcinoma. {ECO:0000269|PubMed:26951679}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Pathway
Signal Transduction;Alpha6Beta4Integrin;a6b1 and a6b4 Integrin signaling;Signaling by MST1;Signaling by Receptor Tyrosine Kinases;amb2 Integrin signaling (Consensus)

Recessive Scores

pRec
0.154

Intolerance Scores

loftool
0.857
rvis_EVS
-1.78
rvis_percentile_EVS
2.29

Haploinsufficiency Scores

pHI
0.326
hipred
N
hipred_score
0.352
ghis
0.513

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.749

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Mst1r
Phenotype
immune system phenotype; liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype;

Zebrafish Information Network

Gene name
mst1rb
Affected structure
bone mineralization
Phenotype tag
abnormal
Phenotype quality
delayed

Gene ontology

Biological process
defense response;signal transduction;transmembrane receptor protein tyrosine kinase signaling pathway;single fertilization;positive regulation of cell population proliferation;response to virus;Wnt signaling pathway;peptidyl-tyrosine phosphorylation;macrophage colony-stimulating factor signaling pathway;positive regulation of MAP kinase activity;innate immune response;hepatocyte growth factor receptor signaling pathway;positive regulation of protein kinase B signaling
Cellular component
stress fiber;vacuole;plasma membrane;integral component of plasma membrane;cell surface;receptor complex
Molecular function
transmembrane receptor protein tyrosine kinase activity;macrophage colony-stimulating factor receptor activity;protein binding;ATP binding;Wnt-protein binding;enzyme binding